These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6339410)

  • 1. Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.
    Bistoni F; Baccarini M; Blasi E; Marconi P; Puccetti P; Garaci E
    Infect Immun; 1983 Apr; 40(1):46-55. PubMed ID: 6339410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-associated macrophage precursor activity: isolation of candidacidal and tumoricidal effectors from the spleens of cyclophosphamide-treated mice.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1986 Feb; 136(3):837-43. PubMed ID: 3079800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector.
    Baccarini M; Bistoni F; Puccetti P; Garaci E
    Infect Immun; 1983 Oct; 42(1):1-9. PubMed ID: 6352489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing resistance and modulation of humoral immune response to experimental Candida albicans infection by patulin.
    Escoula L; Bourdiol D; Linas MD; Recco P; Seguela JP
    Mycopathologia; 1988 Sep; 103(3):153-6. PubMed ID: 3057378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans.
    Sawyer RT; Harmsen AG
    Mycopathologia; 1989 Nov; 108(2):95-105. PubMed ID: 2687694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-organism model of host defense against infection: a novel immunotoxicologic approach to evaluate immunomodulatory drugs.
    Herzyk DJ; Ruggieri EV; Cunningham L; Polsky R; Herold C; Klinkner AM; Badger A; Kerns WD; Bugelski PJ
    Toxicol Pathol; 1997; 25(4):351-62. PubMed ID: 9280118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of cyclophosphamide and thymostimulin treatment on the in vitro natural killer and candidacidal activity of murine spleen cells.
    Baccarini M; Scaringi L; Puccetti P; Falchetti R; D'Errico P; Bistoni F
    Int J Tissue React; 1984; 6(6):485-92. PubMed ID: 6530352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclophosphamide on the course of Candida albicans infection in normal and vaccinated mice.
    Japoni A; Mehrabani D; Alborzi A; Farshad S; Hayati M; Dehyadegari MA
    Saudi Med J; 2006 Jan; 27(1):46-51. PubMed ID: 16432593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans.
    Vecchiarelli A; Cenci E; Marconi P; Rossi R; Riccardi C; Bistoni F
    J Med Microbiol; 1989 Nov; 30(3):183-92. PubMed ID: 2511321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclophosphamide on murine candidiasis.
    Moser SA; Domer JE
    Infect Immun; 1980 Feb; 27(2):376-86. PubMed ID: 6991413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
    Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
    J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice.
    Kullberg BJ; van 't Wout JW; Hoogstraten C; van Furth R
    J Infect Dis; 1993 Aug; 168(2):436-43. PubMed ID: 8335982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1.
    Kullberg BJ; van 't Wout JW; van Furth R
    Infect Immun; 1990 Oct; 58(10):3319-24. PubMed ID: 2144844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.
    Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of mouse resistance to Candida albicans infection by thymosin alpha 1.
    Bistoni F; Marconi P; Frati L; Bonmassar E; Garaci E
    Infect Immun; 1982 May; 36(2):609-14. PubMed ID: 7085074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of polymorphonucleate-mediated cytotoxicity against Candida albicans by thymosin alpha 1.
    Bistoni F; Baccarini M; Blasi E; Riccardi C; Marconi P; Garaci E
    Thymus; 1985; 7(2):69-84. PubMed ID: 3892779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intrinsic and acquired immune cells infiltration in kidney and spleen of the mice infected with systemic candidiasis and treated with chloroform fraction of Zataria Multiflora Boiss.
    Bayat M; Hassannejad N; Ghazanfari H
    Microb Pathog; 2018 Jan; 114():444-448. PubMed ID: 29183758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice.
    Collavo D; Ronchese F; Zanovello P; Cerundolo V; Biasi G
    Int J Immunopharmacol; 1984; 6(5):529-34. PubMed ID: 6334044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.